How do I find out if I qualify for a alk-positive non-small cell lung cancer study in Massachusetts?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Massachusetts to take part?

Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a alk-positive non-small cell lung cancer trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Massachusetts

ALK-positive Non-small Cell Lung Cancer clinical trials in Massachusetts

We’re tracking 3 recruiting alk-positive non-small cell lung cancer studies with a site in Massachusetts — including Phase 1/Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Massachusetts

NCT07491497RecruitingPhase 1/Phase 2
Study of TRI-611 for ALK-positive lung cancer
This trial tests a new investigational drug called TRI-611 for people with ALK-positive non-small cell lung cancer. It is designed for people who have already tried other ALK-targeted medicines, especially lorlatinib, and whose cancer may have stopped responding to them.
Boston, MassachusettsAges 18 years+
NCT06765109RecruitingPhase 3
Testing neladalkib for untreated ALK-positive lung cancer
This study tests a new pill called neladalkib to see if it works better than the current standard treatment (alectinib) for people with ALK-positive lung cancer who have not yet received any cancer therapy for advanced disease. It may be a good option if you have ALK-positive NSCLC and have not been treated before.
Boston, MassachusettsAges 18 years+
NCT04900935Recruiting
Survivorship and palliative care planning for metastatic lung cancer
This study tests a more patient-centered way to plan survivorship care and comfort (palliative) care for people with metastatic lung cancer. It may help you get support that matches your goals, especially alongside your current targeted treatment.
Boston, MassachusettsAges 18 years+

ALK-positive Non-small Cell Lung Cancer trials by city in Massachusetts

Boston

Where these studies are running in Massachusetts

Institutions with a site for the recruiting alk-positive non-small cell lung cancer studies listed above.

Dana-Farber Cancer Institute · 2 studies
Massachusetts General Hospital · 2 studies

What taking part in a alk-positive non-small cell lung cancer study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Common questions

Are there alk-positive non-small cell lung cancer clinical trials in Massachusetts?: Yes. We're currently tracking 3 recruiting alk-positive non-small cell lung cancer studies with a site in Massachusetts, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a alk-positive non-small cell lung cancer study in Massachusetts?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Massachusetts to take part?: Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a alk-positive non-small cell lung cancer trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New alk-positive non-small cell lung cancer studies open in Massachusetts regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.